“Vår teknologi kan verkligen förändra sjukvården”
Bröstsmärta är en vanlig anledning till att söka vård. Men det är bara 10 procent av de som söker vård som till sist diagnostiseras med...
Acarix and the American College of Cardiology announce strategic collaboration
The American College of Cardiology (“ACC”) and Acarix have signed a strategic collaboration agreement with the goal to develop a clinic...
Helen Ljungdahl Round, President and CEO presents at Redeye event, Theme: Diagnostics
On September 27 at 9.00am CEST, Helen Ljungdahl Round, President and CEO at Acarix presented the company´s latest developments within d...
Highlights from the European Society of Cardiology Congress 2022
In the Special Session ‘Best of the European Heart Journal – Digital Health’ Simon Winther, MD, PhD, Gødstrup Hospital, Denmark was inv...
Samuel Schmidt, Co-founder at Acarix has received the Danish MedTech Society’s Rosenfalck Prize.
"At the Annelise Rosenfalck Celebration, I received the Danish MedTech Society’s Rosenfalck Prize for my innovations. Annelise Ros...
Svensk AI-teknik förbättrar utredning av bröstsmärtor i USA
Publicerad i Dagens industri, 21 juni 2022I över 15 år har det svenska medicintekniska företaget Acarix utvecklat den AI-baserade tekno...
Acarix at Naventus Health Care Summit 2022
Helen Ljungdahl Round, President and CEO of Acarix AB (publ), presented at the Naventus Health Care Summit in Stockholm on May 10, 2022...
CADScor®System recognized as Most Innovative Coronary Artery Disease Analytical Device 2021.
Acarix and CADScor®System has won the Global Health & Pharma technology awards 2021 as Most Innovative Coronary Artery Disease Anal...